For research use only. We do not sell to patients.
TCS 21311
CAS No. : 1260181-14-3
Biological Activity:TCS 21311 (NIBR3049) is a potent, highly selective JAK3 inhibitor with an IC50 of 8 nM, it displays >100-fold selectivity over JAK1, JAK2 and TYK2. TCS 21311 (NIBR3049) inhibits PKCα, PKCθ, and GSK3β with IC50s of 13, 68, and 3 nM, respectively.
Research Area:Cancer
Targets:JAK|GSK-3|PKC
Related Small Molecules:AZ-3;TCS2002;[Ala107]MBP(104-118) TFA;JAK3/BTK-IN-1;BJE6-106;AR-A014418;Myelin Basic Protein;AT9283;Staurosporine;Benzene hexabromide;PKC-iota inhibitor 1;(E/Z)-Zotiraciclib;JAK-IN-10;Hypericin;Baricitinib-d3;Malantide;JAK3-IN-6;PKCiota-IN-2 formic;GSK 3 Inhibitor IX;Coumermycin A1;Deucravacitinib;Momelotinib-3,3,5,5-d4;SJ10542;Delgocitinib
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use;
- Structurally and synthetically diverse biologically active compounds;
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.;
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.;
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.;
- Customized order volume ranging from milligrams to kilograms scale;
Structurally and synthetically diverse biologically active compounds;
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.